RETA - Reata Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RETA (1358762)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
37 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-09-14
RETALoewen AndreaSVP, Global Regulatory AffairsS - Sale$172.03-3,17528,416-10%-$546,181
2023-09-05
RETAAnand BhaskarSVP, Chief Accounting OfficerS - Sale$169.20-40624,089-2%-$68,695
M
2023-08-15
RETAWortley Michael DGCS - Sale$168.95-1,20549,701-2%-$203,581
2023-08-16
RETASoni Manmeet SinghCOO, CFO, PresS - Sale$168.41-1,75562,621-3%-$295,566
M
2023-08-15
RETAMeyer Colin JohnChief Innovation OfficerS - Sale$169.00-2,74081,633-3%-$463,052
M
2023-08-15
RETABir Dawn CarterChief Commercial OfficerS - Sale$168.80-1,20533,805-3%-$203,409
M
2023-08-15
RETAAnand BhaskarSVP, Chief Accounting OfficerS - Sale$168.72-40324,495-2%-$67,995
D
2023-07-28
RETASoni Manmeet SinghCOO, CFO, PresS - Sale+OE$164.62-75,00064,376-54%-$12,346,298
D
2023-07-28
RETARuff ShamimDirS - Sale+OE$164.53-8,2357,359-53%-$1,354,887
D
2023-07-28
RETAMcClellan William D. Jr.DirS - Sale+OE$164.49-5,0006,017-45%-$822,442
D
2023-07-28
RETABir Dawn CarterChief Commercial OfficerS - Sale+OE$164.54-40,00035,010-53%-$6,581,428
D
2023-06-14
RETAAnand BhaskarSVP, Chief Accounting OfficerS - Sale+OE$102.11-2,34324,898-9%-$239,248
DM
2023-06-12
RETASoni Manmeet SinghCOO, CFO, PresS - Sale+OE$102.71-82,79658,376-59%-$8,503,640
M
2023-05-15
RETAWortley Michael DGCS - Sale$83.59-1,31146,781-3%-$109,589
M
2023-05-15
RETASoni Manmeet SinghCOO, CFO, PresS - Sale$84.45-22,132116,172-16%-$1,869,150
M
2023-05-15
RETAMeyer Colin JohnChief Innovation OfficerS - Sale$84.56-6,23378,373-7%-$527,063
M
2023-05-15
RETAKhan SaminaSVP, Chief Medical OfficerS - Sale$83.15-64039,491-2%-$53,214
M
2023-05-15
RETAAnand BhaskarSVP, Chief Accounting OfficerS - Sale$85.37-1,08625,679-4%-$92,714
M
2023-05-15
RETABir Dawn CarterChief Commercial OfficerS - Sale$83.77-1,31130,885-4%-$109,829
M
2023-05-12
RETALoewen AndreaSVP, Global Regulatory AffairsS - Sale$86.01-7,16631,591-18%-$616,352
2023-03-13
RETABir Dawn CarterChief Commercial OfficerS - Sale$86.77-9,31732,196-22%-$808,436
D
2023-03-10
RETARuff ShamimDirS - Sale+OE$83.73-5,7405,223-52%-$480,610
D
2023-03-07
RETALoewen AndreaSVP, Global Regulatory AffairsS - Sale+OE$83.43-19,03638,757-33%-$1,588,137
DM
2023-03-06
RETABir Dawn CarterChief Commercial OfficerS - Sale+OE$87.67-96,99641,513-70%-$8,503,621
2023-03-07
RETAAnand BhaskarSVP, Chief Accounting OfficerS - Sale$84.58-16526,765-1%-$13,956
2023-03-07
RETAMeyer Colin JohnChief Innovation OfficerS - Sale$84.57-62184,606-1%-$52,518
2023-03-07
RETASoni Manmeet SinghCOO, CFO, PresS - Sale$84.70-62288,304-1%-$52,680
2023-03-07
RETAWortley Michael DGCS - Sale$84.46-41448,092-1%-$34,966
2023-03-07
RETAKhan SaminaSVP, Chief Medical OfficerS - Sale$83.46-3,96140,131-9%-$330,585
DM
2023-03-02
RETAMeyer Colin JohnChief Innovation OfficerS - Sale+OE$86.72-93,92285,227-52%-$8,145,224
2023-03-03
RETAWortley Michael DGCS - Sale$87.57-2,16948,506-4%-$189,939
2023-03-03
RETASoni Manmeet SinghCOO, CFO, PresS - Sale$87.97-3,58788,926-4%-$315,548
M
2023-03-02
RETALoewen AndreaSVP, Global Regulatory AffairsS - Sale$88.08-1,81942,793-4%-$160,209
DM
2023-03-02
RETAKhan SaminaSVP, Chief Medical OfficerS - Sale+OE$85.13-27,81344,092-39%-$2,367,716
2023-03-03
RETAAnand BhaskarSVP, Chief Accounting OfficerS - Sale$87.47-82026,930-3%-$71,725
2023-03-03
RETABir Dawn CarterChief Commercial OfficerS - Sale$88.25-2,16648,509-4%-$191,148
D
2023-03-02
RETAHuff James WarrenCEOS - Sale+OE$85.46-75,00051,824-59%-$6,409,473

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top